Clinical Trial Update: A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer [Phase 3]

View source ↗

Summary

Phase III study in metastatic hormone-naïve prostate cancer sponsored by UNICANCER is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: UNICANCER | Conditions: Metastatic Prostate Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING